Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Clinical trial NCT07410494 · RECRUITING

Trial details

NCT number: NCT07410494
Sponsor: Essen Biotech
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancer Breast Cancer Non-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (Locally Advanced or Metastatic)Prostate Cancer - Recurrent Pancreatic Ductal Adenocarcinoma (PDAC)Ovarian Cancer Glioblastoma Melanoma (Skin Cancer)Acute Myeloid Leukemia (AML)Non Hodgkin Lymphoma Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma

Start date: 2026-02-01
Primary completion: 2027-12-28
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.